Autoantibodies News and Research

RSS
New insights into how myasthenia gravis antibodies disrupt muscle function

New insights into how myasthenia gravis antibodies disrupt muscle function

Conversations on AFM: Exploring the nanomechanics of living cells

Conversations on AFM: Exploring the nanomechanics of living cells

UZH researchers develop decoy molecules to restore immune defense

UZH researchers develop decoy molecules to restore immune defense

Establishing common nomenclature for mitochondria transfer and transplantation

Establishing common nomenclature for mitochondria transfer and transplantation

Study finds potential target for stopping immune system attacks in autoimmune diseases

Study finds potential target for stopping immune system attacks in autoimmune diseases

Scientists discover how viral infection triggers autoimmune disease

Scientists discover how viral infection triggers autoimmune disease

New insights into Sjögren's disease pathogenesis and treatment

New insights into Sjögren's disease pathogenesis and treatment

New initiative aims to explore diet’s role in lupus care

New initiative aims to explore diet’s role in lupus care

Lupus Research Alliance launches first Translational Bridge Award to accelerate lupus treatments

Lupus Research Alliance launches first Translational Bridge Award to accelerate lupus treatments

Emerging therapies transform autoimmune hepatitis treatment approaches

Emerging therapies transform autoimmune hepatitis treatment approaches

Study links nasal autoantibodies to COVID-19 severity prediction

Study links nasal autoantibodies to COVID-19 severity prediction

Genetic and environmental drivers shape early type 1 diabetes risk in children

Genetic and environmental drivers shape early type 1 diabetes risk in children

Lupus Research Alliance announces 33 studies to be presented at ACR Convergence 2024

Lupus Research Alliance announces 33 studies to be presented at ACR Convergence 2024

Mortality risk higher for those diagnosed with type 2 diabetes at younger ages

Mortality risk higher for those diagnosed with type 2 diabetes at younger ages

Targeted therapy improves pregnancy outcomes

Targeted therapy improves pregnancy outcomes

A faster, cheaper method to detect immune autoantibodies in whole blood

A faster, cheaper method to detect immune autoantibodies in whole blood

Johnson & Johnson seeks first approval of nipocalimab to treat broadest population living with antibody positive generalized myasthenia gravis

Johnson & Johnson seeks first approval of nipocalimab to treat broadest population living with antibody positive generalized myasthenia gravis

Lupus Research Alliance announces 2024 Diversity in Lupus Research Award recipients

Lupus Research Alliance announces 2024 Diversity in Lupus Research Award recipients

New insight into the causes of autoimmune diseases

New insight into the causes of autoimmune diseases

Cancer drug offers life-changing results for severe lupus patient

Cancer drug offers life-changing results for severe lupus patient

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.